From JANUVIA to MARIZEV (Omarigliptin), a once weekly DPP-4 inhibitor for the treatment of diabetes

被引：0
|
作者：
Weber, Ann [1 ]
机构：
[1] Kallyope Inc, New York, NY USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2018年 / 255卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
15
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of once-weekly GLP-1 RA in patients with type 2 diabetes treated with DPP-4 inhibitor
    Murakami, Masako
    Hirahara, Naoko
    Morita, Hiroshi
    Sasaki, Shigekazu
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S105 - S105
  • [32] Sitagliptin: A DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
    Johnson, Kathryn M. S.
    Schurr, Kathleen
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 81 - 92
  • [33] Design and synthesis of DPP-4 inhibitor for the treatment of type 2 diabetes
    Peng Cho Tang
    Chinese Chemical Letters, 2010, 21 (03) : 253 - 256
  • [34] Design and synthesis of DPP-4 inhibitor for the treatment of type 2 diabetes
    Tang, Peng Cho
    Lin, Zhi Gang
    Wang, Yang
    Yang, Fang Long
    Wang, Qian
    Fu, Jian Hong
    Zhang, Lei
    Gong, Ai Shen
    Luo, Jing Jing
    Dai, Jun
    She, Gao Hong
    Si, Dan Dan
    Feng, Jun
    CHINESE CHEMICAL LETTERS, 2010, 21 (03) : 253 - 256
  • [35] Efficacy of omarigliptin, once-weekly dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes
    Kawasaki, Eiji
    Nakano, Yuko
    Fukuyama, Takahiro
    Uchida, Aira
    Sagara, Yoko
    Tamai, Hidekazu
    Tojikubo, Masayuki
    Hiromatsu, Yuji
    Koga, Nobuhiko
    WORLD JOURNAL OF DIABETES, 2021, 12 (12) : 2087 - 2095
  • [36] Once-weekly DPP-4 inhibitors: do they meet an unmet need?
    Scheen, Andre J.
    LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (03): : 162 - 164
  • [37] Use of Prohibited Medication, a Potentially Overlooked Confounder in Clinical Trials: Omarigliptin (Once-weekly DPP-4 Inhibitor) Monotherapy Trial in 18-to 45-year-olds
    Gantz, Ira
    Sokolova, Liubov
    Jain, Lokesh
    Iredale, Carol
    O'Neill, Edward A.
    Wei, Ziwen
    Lam, Raymond
    Suryawanshi, Shailaja
    Kaufman, Keith D.
    Engel, Samuel S.
    Lai, Eseng
    CLINICAL THERAPEUTICS, 2017, 39 (10) : 2024 - 2037
  • [38] Once-weekly DPP-4 inhibitors: The clinical efficacy and treatment satisfaction in 51 Japanese patients with type 2 diabetes mellitus
    Tosaki, Takahiro
    Kamiya, Hideki
    Himeno, Tatsuhito
    Kato, Yoshiro
    Kondo, Masaki
    Inagaki, Akemi
    Yamamoto, Yuka
    Tsubonaka, Kaori
    Oshiro, Chie
    Nakaya, Yuki
    Hayasaki, Tomoyo
    Nakamura, Jiro
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S127 - S127
  • [39] Saxagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus
    Abd A. Tahrani
    Milan K. Piya
    Anthony H. Barnett
    Advances in Therapy, 2009, 26 : 249 - 262
  • [40] Sitagliptin: Profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetes
    Gallwitz, Baptist
    DRUGS OF TODAY, 2007, 43 (01) : 13 - 25
12345